xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subject_decs
Ara mostrant els elements 1-1 d 1
-
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Lippincott Williams & Wilkins, 2021-07)